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Abstract
Background: Carotid body tumours (CBTs) are very rare lesions which should be treated as soon
as possible even when benign since small tumour size permits easier removal and lower incidence
of perioperative complications and recurrence. Malignant forms are rare and they can be identified
by lymph node invasion and metastases in distant locations. The need of reliable and effective
diagnostic modalities for both primary CBTs and its metastases or recurrence is evident.
The present study reviews our experience and attempt to define the role of colour coded
ultrasound (CCU) and Somatostatin receptor scintigraphy (SRS) with Indium-111-DTPA-
pentetretide (Octreoscan®) using both planar and single photon emission tomography (SPECT)
technique in the diagnosis and follow-up of these uncommon lesions within a multidisciplinary
approach.
Methods: From 1997 to 2008, 12 patients suffering from 16 CBTs (4 bilateral) were investigated
by CCU and SRS-SPECT before and after surgery. All tumours were grouped according to
Shamblin's classification in order to assess the technical difficulties and morbidity of surgical
resection on the ground of their size and relationship with the carotid arteries. Intraoperative
radiocaptation by Octreoscan®) was also carried out in all cases to evaluate the radicality of
surgery. All perioperative scans were evaluated by the same nuclear medicine physician.
Results: Preoperatively CCU showed CBTs (four were not palpable) with a sensitivity of 100%.
Radioisotope imaging identified the CBTs as chemodectomas in 15 cases while no radioisotopic
uptake was detected in 1 vagus nerve neurinoma. No evidence of metastasis or multicentricity
were seen by total body radioisotopic scans. Combined data from CCU and SRS-SPECT allowed
to determine tumour size in order to select 7 larger tumours which were submitted to selective
preoperative embolization.
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Intraoperatively Octreoscan demonstrated microscopic tumour leftovers promptly removed in 1
case and an unresectable remnant at the base of the skull in another case.
During follow-up CCI and radioisotope scans showed no recurrence in 14 cases and a slightly
enlargement of the intracranial residual as detected during surgery in 1 patient.
Conclusion:  CCU may allow an early and noninvasive detection of CBTs and hence safer
operations. The combined use of CCU and SRS-SPECT provide useful data to identify those
tumours and to evaluate their extent and carotid arteries infiltration. Radioisotope imaging is a
sensitive modality to detect metastases and lymph node involvement that are markers of CBT
malignancy. After surgery CCU and SRS-SPECT can be accurate modalities for surveillance for an
early detection of CBTs recurrence.
Introduction
Carotid body tumours (CBTs) are rare neck tumours typi-
cally located at the carotid bifurcation. They are uncom-
mon non chromaffin paragangliomas (PGs) and contain
somatostatin receptor sites which enable localization by
somatostatin receptor scintigraphy (SRS) with Indium-
111-DTPA-pentetretide (Octreoscan®) using both planar
and single photon emission tomography (SPECT) tech-
niques; this modality allows to identify both the primary
tumour, bilaterality, metastases in distant locations and
recurrence which is reported in about 6% of cases [1] after
surgery.
The main signs and symptoms of CBT include a slow
growing pulsating mass at the level of carotid bifurcation
and a peripheral cervical neuropathy related to the largest
tumours but they may be clinically silent for a long time
even when malignant.
The CBT is generally benign but also the benign forms
have no true capsule and grow progressively, adhering to
and encasing the vessels and nerves, compressing and dis-
locating the pharynx and even eroding the base of the
skull; therefore they should never be left untreated even
when they are supposed to be benign. In addition to the
potential for adjacent tissue infiltration, they can be bilat-
eral in up to 5% of cases [2]. Malignant form is suggested
to be only around 5-10% [3] and only the lymph node
invasion and metastases in distant locations (head, neck,
chest, abdomen and pelvis) can identify the malignancy
since mitotic figures or nuclear abnormalities may not
always be found.
The natural history of those tumours can be unpredictable
even for the benign ones and an early surgical excision at
presentation is advisable since they may destroy glos-
sopharingeal, vagal, hypoglossal and recurrent laryngeal
nerves or invade the adjacent carotid arteries making the
surgical management problematic according to Shamb-
lin's clinicopathologic analysis [4].
Reliable and effective diagnostic methods for both pri-
mary CBTs and its metastases or recurrence are needed.
According to our previous experience and the data from
literature [5,6], CBTs diagnosis can be carried out by col-
our coded ultrasound (CCU) at an early stage even before
they become palpable. Computed tomography angiogra-
phy with contrast medium administration (angio-CT) can
further investigate both carotid arteries and CBTs and
minimize the need for diagnostic conventional angiogra-
phy that may be limited to those patients with indetermi-
nate findings and within preoperative endovascular
embolization of the afferent vessel performed to reduce
tumor mass. Magnetic resonance angiography with con-
trast medium administration (angio-MR) is a reliable
alternative to CT. Both angio-CT and angio-MR of the
neck are sensitive to assess the presence of tumours at the
carotid bifurcation and the relationship of the tumour
with the adjacent structures but they do not provide data
about the potential for malignancy and postoperative
early recurrence because the tumors are too small with
respect to their resolution power. As far as angio-CT con-
cerns, it also causes a substantial exposure to ionizing
radiations in a patient in which a total-body scanning has
to be performed to detect potential metastases or multi-
centricity. MR angiography cannot be performed in
patient with pacemaker or stainless stell prosthesis. More-
over those diagnostic modalities yield a risk of neph-
ropaty and adverse effects due to contrast media
administration. The nuclear medicine images obtained by
SRS-SPECT have shown to be very accurate to determine
the nature of the neck mass and to localize the CBTs; radi-
oisotope scans also allow to detect areas of possible
metastases throughout the body and to discover postoper-
ative early recurrence.
The present study reviews our experience in perioperative
use of CCU and SRS-SPECT for screening test, diagnostic
confirmation and follow-up of CBTs within a multidisci-
plinary team approach in an effort to reduce the need ofJournal of Experimental & Clinical Cancer Research 2009, 28:148 http://www.jeccr.com/content/28/1/148
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more invasive conventional imaging methods (CT, MR
and angiography).
Methods
From January 1997 to June 2008, 12 patients operated
upon for 16 carotid body tumours (bilateral in 4 cases)
were submitted to perioperative somatostatin receptor
scintigraphies; before surgery and during follow-up the
tracer used was indium-111-DTPA-pentetreotide (Ocreos-
can ®) and the technique employed in this investigation
was both planar and single photon emission tomography
(SPECT); during surgery a gamma-probe was used.
The patient data taken into account were: age, gender,
tumour size, bilaterality, postoperatively mortality and
morbidity and recurrence during follow-up.
Average age was 51 years (range: 24-74 years) and 40% of
patients were males.
CCU was performed as the first diagnostic approach in all
patients with an Ultramark 9 ATL Philiphs equipment in
the first part of this experience and with a Toshiba Aplio
XP equipment successively. Typical ultrasound features
included the presence of a solid hypoechoic vascular mass
with a low-resistance flow pattern at Doppler frequency
analysis, a hypervascular pattern at colour and power
Doppler imaging; CCU also showed intrinsic carotid dis-
ease if present.
Neck angio-CT and angio-MR were combined to ultra-
sounds to define tumour feeding vessels, the relationship
with the adjacent structures and the cranial extension in
the neck for a better planning of the best surgical
approach. Total body angio-CT was not performed to
minimize the risks related to the high dose of radiation
burden for CT.
Digital substraction carotid angiography (DSA) was car-
ried out in those cases scheduled for endovascular preop-
erative embolization performed in order to reduce
tumour vascularity and size; embolization was always fol-
lowed by operation within 1 or 2 days. During DSA, con-
temporary balloon internal carotid blockade (Mata's test)
was performed to determine the patient's tolerance to
carotid cross-clamping. The sensitivity of this test was
improved by the use of transcranial Doppler monitoring.
Preoperative total body SRS- SPECT was carried out by
intravenous injection of 150 MBq 111In-pentetretide
(StarCam 2000 at first and then StarCam 4000i). Nuclear
scans included head, neck, chest, abdomen and pelvis and
were repeated at 4 and 24 hours after injection with
medium energy collimators and both 171 keV and 245
keV with a 15% window. The protocol included a 40-
minute acquisition on 128 × 256 matrix. SPECT images
were obtained by 30-minute acquisition on 64 × 64
matrix by using the same collimators.
All perioperative scans were evaluated by the same nuclear
medicine physician.
If abnormal radioactivity was detected in other regions of
the body than neck, nuclear scans would have been
repeated for the same areas during the follow-up.
Table 1 summarizes the diagnostic methods employed for
pre-operative evaluation in all cases.
When CCU and radioisotopic scans demonstrated a very
high tumour site above the angle of the mandible, a
multidisciplinary treatment involving vascular and maxil-
lofacial teams was planned.
All tumours were grouped according to Shamblin's classi-
fication in order to assess the difficulty and morbidity of
surgical resection: group I included all small tumours non
yet adhering to the carotids; group II included larger
tumours partially encasing the vessels and adhering the
nerves whose dissection may cause nerve damage; group
III included largest tumours completely encasing carotid
arteries with a high danger for nerves and need for carotid
resection and reconstruction.
Intraoperative radio-localization was carried out on all
lesions by a hand-held gamma-detecting probe connected
to a special counting unit (Octreoscan-Navigator-USSC)
within 24 hours radiopharmaceutical administration by
the same nuclear medicine physician than preoperative
scanning. Radioactivity measurements were undertaken
on the tumour in vivo compared with the background on
the tumour bed to detect remnants and on lymph nodes
to reveal invasion.
Table 1: Preoperative investigation modalities in 16 CBTs
Technique n. CBTs (%)
Color-coded imaging 16 (100%)
Indium 111In-pentreotide scintigraphy -SPECT* 16 (100%)
Angio-MR 7 (58.3%)
Angio-CT 9 (75%)
Digital selective angiography** 8 (66.6%)
* Body images were acquired from head, neck, chest, abdomen and 
pelvis
** Preoperative embolization was carried out in 7 out of 8 cases 
submitted to selective carotid angiographyJournal of Experimental & Clinical Cancer Research 2009, 28:148 http://www.jeccr.com/content/28/1/148
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The carotid arteries were exposed through a standard cer-
vicotomy, hypoglossal and vagus nerves were always iden-
tified and the common, internal and external carotid
arteries were dissected. Resection was always attempted
from the inferior margin of the tumour at the carotid
bifurcation and extended onto the internal and external
carotid arteries.
Preoperative CCU and radiosotopic scans suggested the
need of a treatment involving vascular and maxillofacial
teams in 4 patients and intraoperative findings confirmed
the need of that multidisciplinary approach.
None of the 5 Shamblin's class I tumours required an
internal carotid artery resection although in 1 case exter-
nal carotid artery was interrupted; they all were fairly eas-
ily removed without neurological complications.
Ablation of the 5 CBTs in Shamblin's class II required: 2
external carotid artery resection, 1 carotid bifurcation
PTFE patch angioplasty and 2 internal carotid artery
replacement with a ASV graft.
At surgery all tumours of Shamblin's class III extended
very high above the angle of the mandible and required
digastric and pre-stilomastoid muscle resection plus verti-
cal osteotomy of the mandibular ramus to get a wider
space near the skull base. A forewarned maxillo-facial sur-
gical team always resected and later reconstructed the
mandibular bone in order to treat those CBTs.
A CBTs ablation with carotid arteries resection and inter-
nal carotid artery replacement (2 PTFE-TW and 2 ASV
grafts) was carried out in all cases combined to external
carotid artery resection in 2.
The patient suffering from vagus nerve neurinoma had the
nerve resection; in another case vagus, hypoglossal and
superior laryngeal nerves interruption was mandatory to
allow complete removal of adhering tumours.
The pathologic examination of the tumour and sampling
of jugular lymph nodes were carried out in all cases.
Follow-up included CCU examination and radioisotopic
scans at 1, 6 and 12 months postoperatively and every 12
months after the first year to show local recurrence and to
control arterial reconstruction. When any abnormal trac-
ers of CBTs were identified, CT or MR scans from those
areas were obtained to confirm.
Results
The CCU failed in a sharp evaluation of tumour size and
its superior level in the neck in 2 cases (13.3%) when
compared with CT and MR techniques data and with
Octreoscan SPECT imaging.
Preoperatively, In-111 pentectreotide uptake by nuclear
scans (Figure 1) was high in all tumours detected by ultra-
sounds but one that was a neurinoma originating from
vagus nerve as confirmed intraoperatively and by histo-
logical data.
Compared with SRS-SPECT, CCU showed a good diag-
nostic accuracy with a sensitivity and a specificity of 100%
and 93.7% respectively.
Preoperatively ultrasounds data and radioisotopic scan
findings were combined to group CBTs on the ground of
their estimated size and their relationship with the adja-
cent vessels (Table 2). On the ground of preoperative size
measurement, CBTs embolization was carried out for the
largest 3 tumors of group II and for the 4 CBTs of group III
(43.7%) and led to shrinkage of tumour and reduction of
its vascularity in 6 out of 7 cases (85.7%) (figure 2).
At surgery 5 CBTs were classified on size as Shamblin's
class 1 and they all could be easily dissected from carotid
arteries since they didn't adhere to the carotid arteries, 5
were in Shamblin's class 2 and partially encircled carotid
bifurcation; the remaining 5 tumours were in class 3 since
they were strongly adherent to carotid vessels and surgical
resection in a periadventitial plane was not possible. Table
3 summarizes intraoperative measurements of all
tumours; they ranged from 1.4 to 2.7 cm for CBTs in class
I (mean size 2.0 cm), from 1.8 to 3.6 cm for class II (mean
size 2.7 cm) and from 4.5 to 5.1 cm for class III (mean size
5 cm).
Preoperative CCU tumor measurements agreed with
intraoperative Shamblin's classification. Preoperative
CCU and radioisotopic scans suggested the need of a treat-
ment involving vascular and maxillofacial teams for 4
patients and that multidisciplinary approach was con-
firmed to be useful by intraoperative findings.
A) Markedly increased focal tracer uptake in the right cervi- cal region in both planar and B) SPECT scans due to a mas- sive chemodectoma at the right carotid bifurcation Figure 1
A) Markedly increased focal tracer uptake in the 
right cervical region in both planar and B) SPECT 
scans due to a massive chemodectoma at the right 
carotid bifurcation.Journal of Experimental & Clinical Cancer Research 2009, 28:148 http://www.jeccr.com/content/28/1/148
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During surgery gamma probe (figure 3) showed no radi-
otracer uptake from the neurinoma and identified all
CBTs which had more than twofold radioisotopic uptake
as compared to background (mean tumor/background
ratio: 3.02).
After removal, by means of radioactivity measurement in
the tumour bed a small leftovers of tumour tissue partially
encasing the internal carotid artery wall was discovered
and required a more accurate resection followed by
carotid bifurcation PTFE angioplasty in 1 case (6.6%).
In another case radiotracer uptake by an unreseactable
remnant was recorded at the base of the skull not even
detected by other subsequent imaging methods (6.6%)
performed during follow-up.
Radioactivity measurements on lymph nodes never
revealed tumour invasion.
The pathologic results confirmed the diagnosis of CBT in
15 cases and showed no metastasis both in jugular lymph
nodes and carotid arteries. Lymph nodes sampling
showed no residual disease.
Perioperative mortality was nil. No intraoperative brain
ischemia occurred. Deviation of tongue was seen after sur-
gery in 3 cases (21%) but disappeared in a few days. Five
patients (30%) sustained permanent cranial nerve injuries
causing dysphonia in 3 case that was associated with dys-
phagia in 1 and with dysphagia and total tongue deviation
in another case. Postoperative course was uneventful in all
cases. (figure 4)
During follow-up (from 4 months to 10 years; median 3.6
years) clinical, CCU and Octreoscan SPECT of carotid
arteries were performed at 6 and 12 months after surgery
and yearly thereafter.
These controls showed no signs of recurrence in all cases.
Nuclear scan confirmed the presence of the intracranial
remnant in 1 case as detected intraoperatively which
slightly enlarged without clinical evidence within the fol-
lowing 8 years making further CT or MR controls unnec-
essary.
Discussion
Since the first report in 1891 [7], there have been a large
number of sporadic reports in literature concerning
carotid body tumours. CBT is bilateral in approximately
5% of cases and 33% of the sporadic and familial forms
respectively [8] and it usually presents as a gradually
enlarging mass that is incidentally identified.
Although malignant forms of those tumours are suggested
to be only around 5%, the early surgical excision of CBTs
at presentation is mandatory because of their locally inva-
sive nature and the uncertainty about their natural history
[9]. They may grow unpredictably and destroy glos-
sopharingeal, vagal, hypoglossal and or recurrent laryn-
geal nerve [10]. They can also invade the adjacent carotid
arteries making surgical management problematic and
Conventional angiography showing a carotid body tumor  (left) and its selective embolization (right) Figure 2
Conventional angiography showing a carotid body 
tumor (left) and its selective embolization (right).
Table 2: Preoperative classification of CBTs on ground of size measurements and relationship with adjacent vessels on CCU and 
radioisotopic scans (111In-pentetreotide scintigraphy -SPECT)
Group Numper of patients Mean size on CCU Mean sixe on 
radioisotopic sacns
of CBTs on the ground 
of size measurements 
and relationship with 
adjacent vessels on CCU
of CBTs on the ground of 
size measurements and 
relationship with adjacent 
vessels on radioisotopic 
scans
I 5 16 mm 18 mm well defined not adhering
II 5 28 mm 31 mm partially defined partially adhering
III 5 43 mm 47 mm undefined strongly adeheringJournal of Experimental & Clinical Cancer Research 2009, 28:148 http://www.jeccr.com/content/28/1/148
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indicating the need of CBTs as soon as the diagnosis is
established.
The larger the tumour the more difficult is the resection,
and the more neural and vascular injuries occur, so the
diagnosis of CBTs should be as earlier as possible. Lack of
clinical diagnosis has been reported in up to 30% of
patients since these neoplasm can be confused with
enlarged lymph nodes or brachial cysts or salivary glands.
The advent of new imaging modalities allow their detec-
tion at an earlier stage even before they become clinically
evident. CT or MR angiography (MR) are reliable diagnos-
tic techniques to evaluate CBTs and their potential multi-
centricity or recurrence. The main concerns about CT are
the need of contrast medium administration related to
potential adverse effects (eg. acute renal failure) and radi-
ation burden with their inherent risks. MR angiography
cannot be performed when patient has pace maker or
stainless stell prosthesis. Further limitation to the use of
that modality is the risk of nephropaty and nephrogenic
systemic fibrosis due contrast medium administration.
These drawbacks make those imaging techniques unfit for
preclinical screening and long-term follow-up of CBTs.
In our experience CCU proved to be useful and very sen-
sitive for detection of CBTs before the onset of symptoms;
it also allows the differential diagnosis with other neck
mass avoiding ill-advised biopsy. Our experience is con-
sistent with those of several series [11,12] that indicate
Duplex scanning as a non-invasive method for screening
evaluation of even small tumours and for their subse-
quent earlier treatment. This is a crucial point since avail-
able reports suggest cranial nerves and vessels injures are
more likely related to locally advanced disease rather than
operative techniques.
Ultrasounds study alone may fail in a precise evaluation
of size and superior level in the neck of larger tumours
when compared with angio-CT and intraoperative meas-
urements [13]. In our series CCU could establish a defin-
itive diagnosis to proceed with surgery only for tumours
less than 2 cm while required further adjunctive instru-
mental techniques for larger neoplasms. Both CCD and
radiological imaging didn't provide any information for
differential diagnosis between chemodectomas and vagus
nerve neurinoma that was obtained by 111In-pentetre-
otide scintigraphy -SPECT scans. Moreover combination
of CCU evaluation and 111In-pentreotide scintigraphy -
SPECT scans may help not only to localize the suspected
paragangliomas at neck but also to determine their
nature, size and involvement of adjacent structures on the
ground of the tumour's somatostatin receptors. Earlier
hystologic studies indicated an high incidence of CBT
malignancy on the ground of their mitotic activity, capsu-
lar invasion and pleomorphism but the reports by Martin
[14] and Westerband [15] suggest that CBT's metastasis to
regional lymph nodes, brain, bone, liver and lungs are the
actual hallmark of malignancy; they occur from 5 to 10%
and can be reliably detected by radioisotope scans.
In our series radioisotopic scan allowed to exclude poten-
tial multicentricity and metastasis of CBTs in an accurate
fashion [16,17] and it is far less invasive than total body
angio-CT scanning as far as radiation exposure and con-
trast media toxicity concern [18].
In our study a good correlation between preoperative clas-
sification based on CCU imaging and radioisotopic meas-
urement and Shamblin's intraoperative classification was
found.
Table 3: Intraoperative Shamblin's classification and size of 
CBTs
Shamblin's class n° Size range Mean size
I 5 1.4-2.7 cm 2.0 cm
II 5 1.8-3.6 cm 2.9 cm
III 5 4.5-5.1 cm 5.0 cm
A) The gamma probe and meter system used in all patients in  our study Figure 3
A) The gamma probe and meter system used in all 
patients in our study. B) its intraoperative use.
A) Intraoperative image showing a carotid body tumor at  carotid bifurcation Figure 4
A) Intraoperative image showing a carotid body 
tumor at carotid bifurcation. B) The same case after 
resection and reconstruction of the mandibular bone.Journal of Experimental & Clinical Cancer Research 2009, 28:148 http://www.jeccr.com/content/28/1/148
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Data from CCU and radioisotopic investigations allowed
to plan a multidisciplinary treatment for Shamblin II and
III CBTs which encase and or infiltrate carotid arteries and
other adjacent structures making dissection difficult even
in the benign forms.
CCU and nuclear evaluation also provided useful infor-
mation for selective preoperative embolization. Accord-
ing with other authors [19], we believe that the apparent
benefits of embolization should be weighed against the
risk of stroke and that procedure should be limited to
infiltrating tumours greater than 3 cm in diameter; an
accurate pre-operative evaluation by ultrasounds and
nuclear methods can be useful for selection of greater and
more invasive tumours to be treated by embolization. A
further advantage of the early detection and resection of
smaller lesion is the lower need of preoperative emboliza-
tion and its attendant risks [20].
Additionally a reliable radioisotopic evaluation of the dis-
tal extension of tumours above the angle of the mandible
suggest the need of a combined surgical team of maxillo-
facial and vascular surgery for the distal internal carotid
exposure as high as possible at the skull base by mandib-
ulotomy within a multidisciplinary team treatment of this
disease to reduce the incidence rate of peripheral neuro-
logical complications that can occur during the resection
of all CBTs.
The risk of tumour recurrence is related to minimal lefto-
vers which can be missed by surgical resection [21]. Intra-
operative gamma probe radioactivity measurement on the
tumour in vivo compared with the background on the
tumour bed allows to detect tiny remnants so that even
the smallest ones can be readily identified and removed.
These remnants may be removed by a more radical radi-
oguided revision of carotid arteries and resection of adja-
cent tissues. Radiotracer uptake shows also inoperable
residuals that need a careful surveillance during follow-up
[22].
During follow-up serial controls by ultrasounds and
Octreoscan SPECT may be used to evaluate carotid arteries
reconstruction and to detect the recurrence of tumour at
the level of carotid bifurcation in the effort to reduce the
need of more invasive CT or MR controls. Nuclear con-
trols has also showed to be a reliable modality to follow
the growing of unresectable residuals not detectable by
CCU.
Conclusion
Even for benign forms, resection of whole CBTs is recom-
mended as soon as the diagnosis is established because of
their unpredictable local invasive behaviour. Advances in
diagnostic modalities based on ultrasounds and radioiso-
tope imaging have increased earlier discovery of those
tumours even before they become palpable. The nuclear
images obtained by Octreoscan SPECT is shown to be very
accurate to determine the nature of the neck mass and to
localize the CBTs; SPECT scan also allows to detect areas
of potential postoperative early recurrence.
A reliable preoperative evaluation of tumour details con-
cerning their size, extent and relationship with adjacent
vessels can be obtained by combining the two techniques
and allow to plan when a multidisciplinary approach
should be used to treat these patients involving the fields
of vascular surgery, otolaryngology, maxillofacial and
radiology. The early detection and an accurate measure-
ments of larger lesions also provide an additional advan-
tage by decreasing the need for preoperative embolization
and its attendant risks. An early diagnosis permits an ear-
lier treatment of smaller CBTs minimizing the risk of cra-
nial nerves and vessels injures.
Radioactivity measurements performed during surgery is
helpful to detect leftovers of tumour tissue, even the
smallest ones which could be missed without the help of
Octreoscan. Since even tiny remnants may lead to recur-
rence, intraoperative radionucleotide investigation can
better define the outcome of surgery.
During follow-up, CCU and radioisotope imaging com-
bined together are sensitive and less invasive methods to
detect potential recurrence and to monitor growth pro-
gression of unresectable remnants of "these curious little
tumors" as defined by F.B. Lund [23].
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
OM and LI carried out the color coded ultrasonographic
studies, participated in the sequence alignment and
drafted the manuscript. RM carried out the Somatostatin
receptor scintigraphy (SRS) with Indium-111-DTPA-pen-
treotide. SS, LI participated in the sequence alignment.
MFG, RG and BG participated in the design of the study
and performed the statistical analysis. FBV conceived of
the study, and participated in its design and coordination.
All authors read and approved the final manuscript.
References
1. Nora JD, Hallett JW, O'Brien PC, Naessens JM, Cherry KJ Jr, Pai-
rolero PC: Surgical resection of carotid body tumors: long-
term survival, recurrence and metastasis.  Mayo Clin Proc 1988,
63:348-52.
2. Farr HW: Carotid body tumors: a 40 year study.  Cancer 1980,
30:260-5.
3. Hammond SL, Greco DL, Lambert AT, McBiles M, Patton GM:
Indium-In 111 penetreotide scintigraphy: application to
carotid body tumors.  J Vasc Surg 1997, 25:905-8.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Experimental & Clinical Cancer Research 2009, 28:148 http://www.jeccr.com/content/28/1/148
Page 8 of 8
(page number not for citation purposes)
4. Shamblin WR, ReMine WH, Sheps SG, Harrison EG: Carotid body
tumor (chemodectoma): clinicopathologic analysis of 90
cases.  Am J Surg 1971, 122:732-9.
5. Sajid MS, Hamilton G, Baker DM, Joint Vascular Research Group: A
multicenter review of carotid body tumour management.
Eur J Vasc Endovasc Surg 2007, 34(2):127-30.
6. Luna-Ortiz K, Rascon Ortiz M, Villavicencio-Valencia V, Granados
Garcia M, Herrera-gomez : Carotid Body tumors review of 20
year experience.  Oral Oncology 2005, 41:56-61.
7. Dias Da Silva A, O'Donnel S, Gillespie D, Goff J, Shriver C, Rich N:
Malignant Carotid body tumor: a case report.  J Vasc Surg 2000,
32(4):821-3.
8. Saldana MJ, Salem LE, Travezan R: High altitude hypoxia and
chemodectomas.  Hum Pathol 1973, 4:251-63.
9. Fruhwirth J, Kock G, Hauser S, Gutschi S, Beham A, Kainz J: Para-
gagliomas of the carotid bifurcation: oncological aspects of
vascular surgery.  Eur J Surg Oncol 1996, 22:88-92.
10. Lack EE: Carotid body paraganglioma.  Washington DC Armed
Force Institute of Pathology 1997:231-42.
11. Muhm M, Polterauer P, Gstottner W, Temmel A, Richling B, Undt G:
Diagnostic and therapeutic approaches to carotid body
tumors.  Arch Surg 1997, 132:279-84.
12. Koopmans KP, Jager PL, Kema IP, Kerstens MN, Albers F, Dullaart RP:
111In-octreotide is superior to 123I-metaiodobenzylguani-
dine for scintigraphic detection of head and neck paragaglio-
mas.  J Nucl Med 2008, 49(8):1232-7.
13. Kasper GC, Welling RE, Wladis AR, Cajocob DE, Grisham AD, Tom-
sick TA, Gluckman JL, Muck PE: A multidisciplinary approach to
carotid paragagliomas.  Vasc Endovasc Surg 2006, 40(6):467-74.
14. Martin CE, Rosenfeld L, Mc Swain B: Carotid body tumors: a 16-
years follow-up of seven malignant cases.  South Med J 1973,
66:1236-43.
15. Westerband A, Hunter GC, Cintora I, Coulthard SW, Hinni ML, Gen-
tile AT, Devine J, Mills JL: Current trends in the detection and
management of carotid body tumors.  J Vasc Surg 1998,
28(1):84-92.
16. Smith JJ, Passman MA, Dattilo JB, Guzman RJ, Naslund TC, Nerreville
JL: Carotid body tumor resection: does the need for vascular
reconstruction worsen outcome?  Ann Vasc Surg 2006,
20(4):435-9.
17. Ozay B, Kurc E, Orhan G, Yucel O, Senay S, Tasdemir M, Gorur A,
Aka SA: Surgery of carotid body tumor: 14 cases in 7 years.
Acta Chir Belg 2008, 108(1):107-11.
18. Litle VR, Reilly LM, Ramos TK: Preoperative embolization of
carotid tumors: when is appropriate?  Ann Vasc Surg 1996,
10(5):464-8.
19. Robinson JG, Shagets FW, Becket WC, Spies JB: A multidiscipli-
nary approach to reducing morbidity and operative blood
loss during resection of carotid body tumor.  Surgery Gynecology
and Obstetrics 1989, 168:166-70.
20. Baskoyannis KC, Georgopoulos SE, Klonaris CN, Tsekouras NS, Fele-
kouras ES, Pikoulis EA, Griniatsos JE, Papalambros El Bastounis EA:
Surgical treatment of carotid body tumors without emboli-
zation.  Int Angiol 2006, 25:40-5.
21. Kollert M, Minovi AA, Draf W, Bockmühl U: Cervical Paragangli-
omas--Tumor Control and Long-Term Functional Results
after Surgery Skull Base.  2006, 16(4):185-191.
22. Filippi L, Benedetti Valentini F, Gossetti B, De Vincentis G, Scopinaro
F, Massa R: Intraoperative gamma probe detection of head
and neck paragangliomas with 111In-pentreotide: a pilot
study.  Tumors 2005, 91(2):173-6.
23. Lund FB: Tumors of the carotid body.  JAMA 1917, 69:348-352.